Lupin has reported results for third quarter ended December 31, 2023 (Q3FY24).
The company has reported over 22-fold jump in its net profit at Rs 916.44 crore for Q3FY24 as compared to Rs 40.4 crore for the same quarter in the previous year. Total income of the company increased by 43.80% at Rs 4,138.91 crore for Q3FY24 as compared Rs 2,878.21 crore for corresponding quarter of the previous year.
On consolidated basis, the company has reported around 4-fold jump in net profit at Rs 618.70 crore for the third quarter ended December 31, 2023 as compared to Rs 157.65 crore for the same quarter in the previous year. Total income of the company increased by 20.43% at Rs 5,226.78 crore for Q3FY24 as compared Rs 4,340.18 crore for corresponding quarter of the previous year.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1502.30 |
Dr. Reddys Lab | 6198.90 |
Cipla | 1402.20 |
Zydus Lifesciences | 957.00 |
Lupin | 1645.00 |
View more.. |